Yuan Dong Biopharmaceutical: Net profit of 50.831 million yuan (RMB) in the first quarter of 2026, down 16.11% year on year

Yuan Dong Biotechnology announces that in the first quarter of 2026, operating revenue was 326 million yuan, a year-on-year increase of 6.75%. Net profit was 50.83M yuan, a year-on-year decrease of 16.11%.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin